Similarly, the reduced LCA-reactive IgA1 in HBV-HCC might distinguish HBV-HCC from other groups, while the elevated LCA-reactive IgG2 in CHB, LC and HBV-HCC might distinguish liver diseases from HC, and even distinguish LC from other groups. The gene discussed is IGHA1; the disease is hepatocellular carcinoma.